Rajesh Kumar
Stock Analyst at HSBC
(4.33)
# 474
Out of 4,413 analysts
16
Total ratings
83.33%
Success rate
11.29%
Average return
Main Sectors:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher | Maintains: Buy | $630 → $660 | $574.99 | +14.78% | 2 | Apr 17, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $246.89 | +13.41% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $484.11 | -4.98% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical | Initiates: Buy | $13 | $13.98 | -7.01% | 1 | Dec 18, 2023 | |
| ABBV AbbVie | Downgrades: Hold | $167 → $156 | $161.72 | -3.54% | 2 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $44.21 | +19.88% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $111.46 | -12.97% | 1 | Jul 14, 2023 | |
| BNTX BioNTech SE | Initiates: Buy | $124 | $89.95 | +37.85% | 1 | Jul 14, 2023 | |
| PFE Pfizer | Initiates: Buy | $50 | $27.18 | +83.96% | 1 | Jul 14, 2023 | |
| MRK Merck & Co. | Initiates: Hold | $123 | $128.80 | -4.50% | 1 | Jul 14, 2023 | |
| LLY Eli Lilly | Initiates: Buy | $560 | $776.75 | -27.90% | 1 | Jul 14, 2023 |
Thermo Fisher
Apr 17, 2024
Maintains: Buy
Price Target: $630 → $660
Current: $574.99
Upside: +14.78%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $246.89
Upside: +13.41%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $484.11
Upside: -4.98%
Teva Pharmaceutical
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $13.98
Upside: -7.01%
AbbVie
Dec 18, 2023
Downgrades: Hold
Price Target: $167 → $156
Current: $161.72
Upside: -3.54%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $44.21
Upside: +19.88%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $111.46
Upside: -12.97%
BioNTech SE
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $89.95
Upside: +37.85%
Pfizer
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $27.18
Upside: +83.96%
Merck & Co.
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $128.80
Upside: -4.50%
Eli Lilly
Jul 14, 2023
Initiates: Buy
Price Target: $560
Current: $776.75
Upside: -27.90%